| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $13.5B | $11.9B | $11.9B | $12.3B | $9.9B | $8.9B | $2.1B | $2.0B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $3.0B | $2.4B | $2.4B | $2.2B | $2.0B | $2.0B | $0.4B | $0.4B |
| Net Income | $1.7B | $0.8B | $-0.4B | $1.4B | $1.2B | $1.2B | $0.3B | $0.2B |
| EPS (Basic) | $4.56 | $2.27 | $-1.27 | $4.05 | $3.55 | $3.56 | $0.77 | $3.25 |
| EPS (Diluted) | $4.56 | $2.27 | $-1.26 | $4.05 | $3.54 | $3.55 | $0.76 | $3.25 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $63.8B | $59.6B | $55.6B | $53.2B | $48.5B | $46.1B | $41.1B | $38.2B |
| Current Assets | $5.1B | $5.1B | $4.2B | $4.2B | $3.3B | $3.1B | $2.4B | $2.3B |
| Cash & Equivalents | $0.1B | $0.0B | $0.1B | $0.4B | $0.1B | $0.1B | $0.0B | $0.1B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $7.8B | $6.7B | $6.3B | $6.8B | $5.8B | $4.9B | $3.6B | $4.1B |
| Stockholders' Equity | $16.2B | $15.0B | $14.2B | $15.5B | $14.6B | $14.1B | $12.6B | $11.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $4.1B | $2.2B | $1.6B | $2.4B | $2.0B | $1.7B | $2.0B | $1.8B |
| Investing Cash Flow | $-4.3B | $-4.5B | $-4.9B | $-4.1B | $-3.4B | $-4.1B | $-3.3B | $-2.4B |
| Capital Expenditures | $4.2B | $4.5B | $4.3B | $3.4B | $3.2B | $2.9B | $2.9B | $2.5B |
| Financing Cash Flow | $0.3B | $2.3B | $2.9B | $2.0B | $1.4B | $2.6B | $1.2B | $0.7B |